Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

A promising hepatocyte-like cell line, CCL-13, exhibits good liver function both in vitro and in an acute liver failure model.

Yang T, Li C, Zhang L, Li M, Zhou P.

Transplant Proc. 2013 Mar;45(2):688-94. doi: 10.1016/j.transproceed.2012.11.012.

PMID:
23498808
2.

Human fetal hepatocyte line, L-02, exhibits good liver function in vitro and in an acute liver failure model.

Hu X, Yang T, Li C, Zhang L, Li M, Huang W, Zhou P.

Transplant Proc. 2013 Mar;45(2):695-700. doi: 10.1016/j.transproceed.2012.09.121.

PMID:
23498809
3.
4.

Transplantation of human thioredoxin gene-modified hepatocytes for treatment of acute liver failure in rat model.

Li H, Jiang N, Zhang J, Wang GS, Yang Y, Chen GH.

Chin Med J (Engl). 2009 Nov 5;122(21):2631-5.

PMID:
19951583
5.

Transplantation of co-microencapsulated hepatocytes and HUVECs for treatment of fulminant hepatic failure.

Qiu L, Wang J, Wen X, Wang H, Wang Y, Lin Q, Du Z, Duan C, Wang C, Wang C.

Int J Artif Organs. 2012 Jun;35(6):458-65. doi: 10.5301/ijao.5000092.

PMID:
22562371
6.

Transplantation of highly differentiated immortalized human hepatocytes to treat acute liver failure.

Kobayashi N, Miyazaki M, Fukaya K, Inoue Y, Sakaguchi M, Uemura T, Noguchi H, Kondo A, Tanaka N, Namba M.

Transplantation. 2000 Jan 27;69(2):202-7.

PMID:
10670627
7.

Hepatoprotective effect of an immortal human fetal hepatic cell transplantation on CCL(4)-induced acute liver injury in mice.

Yan YB, Song H, Zhong BS, Wang ZY, Ying SJ, Wang F.

Transplant Proc. 2010 Sep;42(7):2782-5. doi: 10.1016/j.transproceed.2010.04.066.

PMID:
20832587
8.

Human hepatoma HepaRG cell line engraftment in severe combined immunodeficient × beige mice using mouse-specific anti-Fas antibody.

Jiang L, Li JG, Lan L, Wang YM, Mao Q, You JP.

Transplant Proc. 2010 Nov;42(9):3773-8. doi: 10.1016/j.transproceed.2010.08.064.

PMID:
21094855
9.

Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure.

Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, Kato T, Okochi H, Ochiya T.

J Gastroenterol Hepatol. 2009 Jan;24(1):70-7. doi: 10.1111/j.1440-1746.2008.05496.x. Epub 2008 Jun 25.

PMID:
18624899
10.

Treatment of surgically induced acute liver failure by transplantation of HNF4-overexpressing embryonic stem cells.

Kuai XL, Cong XQ, Du ZW, Bian YH, Xiao SD.

Chin J Dig Dis. 2006;7(2):109-16.

PMID:
16643339
11.

Effects of acute-liver-failure-plasma exposure on hepatic functionality of HepaRG-AMC-bioartificial liver.

Nibourg GA, Hoekstra R, van der Hoeven TV, Ackermans MT, Hakvoort TB, van Gulik TM, Chamuleau RA.

Liver Int. 2013 Apr;33(4):516-24. doi: 10.1111/liv.12090. Epub 2013 Feb 7.

PMID:
23387413
12.

Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells.

Campard D, Lysy PA, Najimi M, Sokal EM.

Gastroenterology. 2008 Mar;134(3):833-48. doi: 10.1053/j.gastro.2007.12.024. Epub 2007 Dec 23.

PMID:
18243183
13.

Hepatic differentiation of liver-derived progenitor cells and their characterization by microRNA analysis.

Chen Y, Zhou H, Sarver AL, Zeng Y, Roy-Chowdhury J, Steer CJ, Sahin MB.

Liver Transpl. 2010 Sep;16(9):1086-97. doi: 10.1002/lt.22111.

14.

The newly established human hepatocyte cell line: application for the bioartificial liver.

Harimoto N, Taketomi A, Kitagawa D, Kuroda Y, Itoh S, Gion T, Tanaka S, Shirabe K, Shimada M, Maehara Y.

J Hepatol. 2005 Apr;42(4):557-64. Epub 2005 Jan 21.

PMID:
15763342
15.

Treatment of surgically induced acute liver failure with transplantation of highly differentiated immortalized human hepatocytes.

Kobayashi N, Miyazaki M, Fukaya K, Inoue Y, Sakaguchi M, Noguchi H, Matsumura T, Watanabe T, Totsugawa T, Tanaka N, Namba M.

Cell Transplant. 2000 Sep-Oct;9(5):733-5.

PMID:
11144975
16.

The role of interferon-γ inducible protein-10 in a mouse model of acute liver injury post induced pluripotent stem cells transplantation.

Chan CC, Cheng LY, Lu J, Huang YH, Chiou SH, Tsai PH, Huo TI, Lin HC, Lee FY.

PLoS One. 2012;7(12):e50577. doi: 10.1371/journal.pone.0050577. Epub 2012 Dec 5.

17.

Characteristics of hepatocytes derived from early ES cells and treatment of surgically induced liver failure rats by transplantation.

Tabei I, Hashimoto H, Ishiwata I, Tachibana T, Akahori M, Ohi S, Kubo H, Satou K, Yamazaki Y, Yanaga K, Ishikawa H.

Transplant Proc. 2005 Jan-Feb;37(1):262-4.

PMID:
15808614
18.

Establishment and characterization of immortalized human hepatocyte cell line for applications in bioartificial livers.

Pan X, Li J, Du W, Yu X, Zhu C, Yu C, Cao H, Zhang Y, Chen Y, Li L.

Biotechnol Lett. 2012 Dec;34(12):2183-90. doi: 10.1007/s10529-012-1025-1. Epub 2012 Aug 29.

PMID:
22930002
19.
20.

Intrasplenic transplantation of encapsulated hepatocytes decreases mortality and improves liver functions in fulminant hepatic failure from 90% partial hepatectomy in rats.

Aoki T, Jin Z, Nishino N, Kato H, Shimizu Y, Niiya T, Murai N, Enami Y, Mitamura K, Koizumi T, Yasuda D, Izumida Y, Avital I, Umehara Y, Demetriou AA, Rozga J, Kusano M.

Transplantation. 2005 Apr 15;79(7):783-90.

PMID:
15818320

Supplemental Content

Support Center